GPSM2 and gastric adenocarcinoma: Subsequent studies on the GPSM2 gene in gastrointestinal cancers included a pan-cancer analysis across ESCA, PAAD, READ, and STAD cancers, demonstrating significant GPSM2 overexpression across all.